Healthcare & Life Sciences
Cellenkos
United Stateswww.cellenkosinc.com/
Cellenkos is a series b startup based in United States. 1 investor tracked.
Activeseries-b
series-b
Stage
2017
Founded
1
Investors
About Cellenkos
Cellenkos is a company founded in 2017 headquartered in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Cellenkos is a clinical-stage biotechnology company focused on developing and commercializing novel T-regulatory (Treg) cell therapies to treat autoimmune and inflammatory disorders.
Explore Cellenkos's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.